Stock WKME WALKME LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News WalkMe Ltd.

Equities

WKME

IL0011765851

Market Closed - Nasdaq
Other stock markets
 21:00:00 26/04/2024 BST 		5-day change 1st Jan Change
7.93 USD +2.06% Intraday chart for WalkMe Ltd. +0.89% -25.68%
04-17 Morgan Stanley Trims Price Target on WalkMe to $11 From $12, Keeps Equalweight Rating MT
04-15 Barclays Adjusts Price Target on WalkMe to $8.50 From $10, Maintains Underweight Rating MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Morgan Stanley Trims Price Target on WalkMe to $11 From $12, Keeps Equalweight Rating
MT
Barclays Adjusts Price Target on WalkMe to $8.50 From $10, Maintains Underweight Rating
MT
WalkMe Cements Category Leadership with Continued AI Innovation, Industry Recognition, and Financial Growth
AQ
KeyBanc Initiates WalkMe at Sector Weight, Sees Revenue Reacceleration Taking Time, Margin Improvement 'Harder to Come by'
MT
WalkMe Ltd. Files Annual Report on Form 20-F
AQ
WalkMe to Present at Upcoming Investor Conference
AQ
Wells Fargo Adjusts Price Target on WalkMe to $14 From $12, Maintains Overweight Rating
MT
Transcript : WalkMe Ltd., Q4 2023 Earnings Call, Feb 21, 2024
WalkMe: Q4 Earnings Snapshot
AQ
WalkMe Ltd. Announces Fourth Quarter and Full Year 2023 Financial Results
AQ
Walkme Ltd. Provides Earnings Guidance for the First Quarter and Full Year 2024
CI
WalkMe Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
WalkMe Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
WalkMe Introduces Workflow Accelerators to Eliminate Friction in Workflows
AQ
Walkme Ltd. Unveils Workflow Accelerators
CI
Enterprises losing more than $1M a week through inefficient technology use, WalkMe report reveals
AQ
WalkMe Announces Date of Fourth Quarter and Full Year 2023 Financial Results and Conference Call
AQ
Jim Nairn of WalkMe Recognized as 2024 CRN® Channel Chief   
AQ
Barclays Downgrades WalkMe to Underweight From Equalweight, Sets Price Target at $10
MT
Morgan Stanley Lifts Price Target on WalkMe to $11 From $10, Keeps Equalweight Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. WKME Stock
  4. News WalkMe Ltd.